US 7579333
Therapy using a combination of raloxifene and alendronate
granted A61KA61K31/445A61K31/4535
Quick answer
US patent 7579333 (Therapy using a combination of raloxifene and alendronate) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Aug 20 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Aug 25 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 20 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/445, A61K31/4535, A61K31/66, A61K31/663